Effects of phosphodiesterase (PDE) IV inhibitors in rat osteoporosis models.

被引：0
作者：
Miyamoto, K
Waki, Y
Kasugai, S
Ohya, K
机构：
[1] KANAZAWA UNIV,KANAZAWA,ISHIKAWA 920,JAPAN
[2] TOKYO MED & DENT UNIV,TOKYO 113,JAPAN
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 1996年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：M682 / M682
页数：1
相关论文
共 50 条
  • [41] Immunosuppressive and anti-inflammatory effects of cyclic AMP phosphodiesterase (PDE) type 4 inhibitors
    Souness, JE
    Aldous, D
    Sargent, C
    [J]. IMMUNOPHARMACOLOGY, 2000, 47 (2-3): : 127 - 162
  • [42] Comparison of phosphodiesterase type 5 (PDE5) inhibitors
    Wright, P. J.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2006, 60 (08) : 967 - 975
  • [43] Guanine analogues as phosphodiesterase 7 (PDE7) inhibitors
    Barlocco, D
    [J]. DRUG DISCOVERY TODAY, 2001, 6 (16) : 859 - 859
  • [44] Phosphodiesterase (PDE) inhibitors in the treatment of lower urinary tract dysfunction
    Ueckert, Stefan
    Oelke, Matthias
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 72 (02) : 197 - 204
  • [45] THE ANTIINFLAMMATORY AND EMETOGENIC PROPERTIES OF PHOSPHODIESTERASE (PDE) INHIBITORS IN CONSCIOUS FERRETS
    DALE, TJ
    BALL, DI
    NIALS, AT
    COLEMAN, RA
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1995, 116 : P91 - P91
  • [46] The Effects of PDE Inhibitors on Multiple Sclerosis: a Review of in vitro and in vivo Models
    Ainatzoglou, Alexandra
    Stamoula, Eleni
    Dardalas, Ioannis
    Siafis, Spyridon
    Papazisis, Georgios
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2021, 27 (20) : 2387 - 2397
  • [47] INHIBITORS OF CAMP-PHOSPHODIESTERASE (PDE) ISOZYMES TYPE-IV AND TYPE-III SUPPRESS FORMATION OF REACTIVE OXYGEN METABOLITES IN CULTURED RAT MESANGIAL CELLS
    CHINI, CCS
    GRANDE, JP
    DOUSA, TP
    [J]. FASEB JOURNAL, 1995, 9 (06) : A1263 - A1263
  • [48] Cyclic nucleotide phosphodiesterase in human bronchial epithelial cells: Characterization of isoenzymes and functional effects of PDE inhibitors
    Dent, G
    White, SR
    Tenor, H
    Bodtke, K
    Schudt, C
    Leff, AR
    Magnussen, H
    Rabe, KF
    [J]. PULMONARY PHARMACOLOGY & THERAPEUTICS, 1998, 11 (01) : 47 - 56
  • [49] Phosphodiesterase inhibitors 9 (PDE9): potential therapeutic agents
    Sawant, O.
    Ghosh, R.
    Kadam, V. J.
    [J]. INDIAN JOURNAL OF PHARMACOLOGY, 2008, 40 : 70 - 70
  • [50] Discovery of new orally active phosphodiesterase (PDE4) inhibitors
    Ochiai, H
    Ishida, A
    Ohtani, T
    Kusumi, K
    Kishikawa, K
    Yamamoto, S
    Takeda, H
    Obata, T
    Nakai, H
    Toda, M
    [J]. CHEMICAL & PHARMACEUTICAL BULLETIN, 2004, 52 (09) : 1098 - 1104
12345